Canada vs Norway: Proportion of isolates with resistance to ciprofloxacin reported to
Canada
55.62
in 2018
Norway
55.6
in 2018
Canada rank
32nd
Norway rank
33rd
Proportion of isolates with resistance to ciprofloxacin reported to over time
- Canada
- Norway
How they compare
Canada currently reports 55.62 against 55.6 in Norway, a difference of 0.02.
The two have swapped places 3 times across 10 shared years of data; in 2009 it was Norway ahead.
Canada ranks 32nd and Norway ranks 33rd of 54 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 80 | 80 | Norway |
| 2010s | 38.69 | 53.33 | 14.64 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to ciprofloxacin reported to, Canada or Norway?
- Canada, at 55.62 against 55.6 in Norway as of 2018.
- What is the difference in proportion of isolates with resistance to ciprofloxacin reported to between Canada and Norway?
- 0.02, with Canada ahead.
- How many years of comparable data are there for Canada and Norway?
- 10 years are reported by both, from 2009 to 2018.
- How do Canada and Norway rank globally for proportion of isolates with resistance to ciprofloxacin reported to?
- Canada ranks 32nd and Norway ranks 33rd of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.